NCT00686998View on ClinicalTrials.gov

Phase IIA Study in Patients With Schizophrenia

PHASE2CompletedINTERVENTIONAL

Enrollment

106

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

Schizophrenia

Interventions

DRUG

AZD2624

Oral Suspension

DRUG

Olanzapine

PO BID

DRUG

Placebo

Trial Locations (1)

Unknown

Research Site, Rockville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY